Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people accessed eye movement desensitisation and reprocessing therapy on the NHS in each of the last three years.
Answered by Jackie Doyle-Price
Improving Access to Psychological Therapies (IAPT) is a National Health Service programme that offers a range of interventions for treating people with depression or anxiety.
Eye Movement Desensitisation Reprocessing is one of the therapies that can be given to a patient referred to IAPT services.
The following table shows the number of referrals to IAPT services in from 2014-15 to 2016-17, for which at least one appointment included Eye Movement Desensitisation Reprocessing as a treatment.
Number of referrals with one or more appointments where Eye Movement Desensitisation Reprocessing was given as a treatment, England, 2014-15 to 2016-17
Year | Referrals |
2016-17 | 6,637 |
2015-16 | 5,295 |
2014-15 | 2,922 |
Source: NHS Digital
Notes:
www.digital.nhs.uk/iaptreports
Medical training is the responsibility of the General Medical Council (GMC), which is an independent statutory body. The GMC has the general function of promoting high standards of education and co-ordinating all stages of education to ensure that medical students and newly qualified doctors are equipped with the knowledge, skills and attitudes essential for professional practice.
The training curricula for postgraduate trainee doctors is set by the relevant medical Royal College, and must meet standards set by the GMC. Whilst curricula do not necessarily highlight specific conditions, they instead emphasise the skills and approaches that a doctor must develop and maintain in order to ensure accurate and timely diagnoses and treatment plans for their patients.
The GMC also sets the standards expected at undergraduate level and approves medical school curricula. In so doing, they set out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate. This is further detailed at the following link:
http://www.gmc-uk.org/education/undergraduate/undergrad_outcomes.asp
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what training his Department provides to NHS doctors on (a) eye movement desensitisation and (b) reprocessing treatment for cases of post traumatic stress disorder.
Answered by Jackie Doyle-Price
Improving Access to Psychological Therapies (IAPT) is a National Health Service programme that offers a range of interventions for treating people with depression or anxiety.
Eye Movement Desensitisation Reprocessing is one of the therapies that can be given to a patient referred to IAPT services.
The following table shows the number of referrals to IAPT services in from 2014-15 to 2016-17, for which at least one appointment included Eye Movement Desensitisation Reprocessing as a treatment.
Number of referrals with one or more appointments where Eye Movement Desensitisation Reprocessing was given as a treatment, England, 2014-15 to 2016-17
Year | Referrals |
2016-17 | 6,637 |
2015-16 | 5,295 |
2014-15 | 2,922 |
Source: NHS Digital
Notes:
www.digital.nhs.uk/iaptreports
Medical training is the responsibility of the General Medical Council (GMC), which is an independent statutory body. The GMC has the general function of promoting high standards of education and co-ordinating all stages of education to ensure that medical students and newly qualified doctors are equipped with the knowledge, skills and attitudes essential for professional practice.
The training curricula for postgraduate trainee doctors is set by the relevant medical Royal College, and must meet standards set by the GMC. Whilst curricula do not necessarily highlight specific conditions, they instead emphasise the skills and approaches that a doctor must develop and maintain in order to ensure accurate and timely diagnoses and treatment plans for their patients.
The GMC also sets the standards expected at undergraduate level and approves medical school curricula. In so doing, they set out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate. This is further detailed at the following link:
http://www.gmc-uk.org/education/undergraduate/undergrad_outcomes.asp
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many asthma inhalers have been issued (a) in England and (b) in each region to (i) adults and (ii) children in each of the last 10 years.
Answered by Steve Brine
The number of prescriptions prescribed in England and dispensed in the community for drugs that are indicated for the treatment of asthma are shown in the attached table. Information is not available by age. These drugs may also be prescribed for conditions other than asthma.
The sum of the data for all National Health Service England Regions does not equal the total England figure, because the total England figure includes unidentified doctors and it is not possible for NHS Business Services Authority Prescription Services to allocate to an NHS England region.
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to intervene in negotiations between NHS England and pharmaceutical company Vertex on the provision of Orkambi to Cystic Fibrosis patients on the NHS.
Answered by Steve Brine
Patients should have access to the most effective and innovative medicines; it is also necessary that Vertex price Orkambi fairly and responsibly. That is why we must go through the right process with NHS England and Vertex, not the Government, working together to secure the best outcome for patients.
NHS England has been in intensive discussions with Vertex to encourage it to lower the cost of Orkambi to a level that would allow NHS England to fund its use without adversely impacting other patients. I and the Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy) have been keeping an extremely close eye on these discussions and wrote to Vertex in April, urging it to commit to pricing that is responsible and proportionate. I also re-iterated this message in the adjournment debate on 17 July, Official report, coulmns 383-4.
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the European Drug Report 2018, published by the European Monitoring Centre for Drugs and Drug Addiction on 7 June 2018, what assessment he has made of the reasons for the rise in cocaine-related deaths in the UK.
Answered by Steve Brine
The European Drug Report 2018 publishes national data from around Europe, and includes drug-related deaths data from the Office for National Statistics. This is available at the following link:
The number of cocaine-related deaths in England and Wales has increased over the last six years. However, this figure includes those deaths involving crack cocaine, and it is unknown which deaths relate to powder cocaine and which relate to crack cocaine. Crack cocaine is often used alongside heroin by the most vulnerable drug users at greatest risk of health harm and death, and heroin deaths are also increasing. Many cocaine deaths are also associated with other drugs.
There has been a recent increase in crack use and Public Health England is working with the Home Office in an England-wide investigation, including an in-depth review in six localities with high crack prevalence, aiming to get a better understanding of the underlying reasons behind the increase, which is expected to lead to improved efforts to reduce crack use and the deaths associated with it.
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
What steps he has taken to reduce inappropriate out-of-area placements for mental health services.
Answered by Jackie Doyle-Price
Inappropriately placing people away from their home area is unacceptable and the Government is committed to eliminating these in non-specialist, acute mental health care by 2020/21. NHS England and NHS Improvement now have a comprehensive national programme supporting reductions in inappropriate placements. Every part of the country now has a clear, realistic plan for ending out of area placements safely by 2021, with many areas having already ended this practice altogether.
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many hospital admissions related to cannabis use there have been in (a) Manchester and (b) the UK in each of the last three years.
Answered by Steve Brine
NHS Digital has provided information in the attached table on the number of finished admission episodes with a primary or secondary diagnosis recorded for cannabis use in England by clinical commissioning group of treatment, 2014-15 to 2016-17.
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many hospital admissions related to ecstasy use there have been in (a) Manchester and (b) the UK in each of the last five years.
Answered by Steve Brine
The information requested on hospital admissions related to ecstasy use, fentanyl and carfentanyl in Manchester and United Kingdom is not held in the format requested.
NHS Digital has provided the attached table on the count of finished admission episodes with a primary or secondary diagnosis recorded for cocaine use, by clinical commissioning group of treatment in England, 2012-13 to 2016-17.
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many hospital admissions related to cocaine use there have been in (a) Manchester and (b) the UK in each of the last five years.
Answered by Steve Brine
The information requested on hospital admissions related to ecstasy use, fentanyl and carfentanyl in Manchester and United Kingdom is not held in the format requested.
NHS Digital has provided the attached table on the count of finished admission episodes with a primary or secondary diagnosis recorded for cocaine use, by clinical commissioning group of treatment in England, 2012-13 to 2016-17.
Asked by: Jeff Smith (Labour - Manchester, Withington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many hospital admissions related to (a) fentanyl and (b) carfentanyl there have been in (a) Manchester and (b) the UK in the last 12 months.
Answered by Steve Brine
The information requested on hospital admissions related to ecstasy use, fentanyl and carfentanyl in Manchester and United Kingdom is not held in the format requested.
NHS Digital has provided the attached table on the count of finished admission episodes with a primary or secondary diagnosis recorded for cocaine use, by clinical commissioning group of treatment in England, 2012-13 to 2016-17.